![Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1885585714000875:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1NQLWG100M7OZEJTign/qk7QbeYCCyuw6a6ycScaDlM3ve8r65UmLCvkPhK/i4zLvWaU8d+isV8nmswilE8vNx1fduE/DZDFuPgpHvaqELtL2CId+ktKY7IQ6b9XOKxfMkNZ/LlQc6NISuFwY5IJr7Ka4t612lDxCCJ84r9JhsKiXkZ2NMumzZNfiFcTjwG32kzVEmMiGwQHIZ75r/Ciw+FkZyaS7tMRpsE38PC8DJdEQ=)
Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología
![Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway](https://www.coventryrugbygpgateway.nhs.uk/wp-content/uploads/2019/10/CHADSVASC-revised-png.png)
Primary Care Initiation of Direct Oral Anticoagulants (DOACs) for Stroke Prevention in Atrial Fibrillation (AF) – GP Gateway
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/d0d191e0-987d-42cc-983f-d06e4fcdb336/e003476fig02.jpg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![PDF] AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score. | Semantic Scholar PDF] AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb3e2d9cbb0608c683f8b3d6c19f1cd1d320a9e1/3-Table1-1.png)
PDF] AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score. | Semantic Scholar
![Chandra Ohri on Twitter: "When should you use anticoagulants for patients with AF? Use #CHADSVASC to determine #Stroke risk for patients with #AF #MedEd https://t.co/OeuaR5s9Fw" / Twitter Chandra Ohri on Twitter: "When should you use anticoagulants for patients with AF? Use #CHADSVASC to determine #Stroke risk for patients with #AF #MedEd https://t.co/OeuaR5s9Fw" / Twitter](https://pbs.twimg.com/media/DzybtAsW0AErtXr.jpg)
Chandra Ohri on Twitter: "When should you use anticoagulants for patients with AF? Use #CHADSVASC to determine #Stroke risk for patients with #AF #MedEd https://t.co/OeuaR5s9Fw" / Twitter
![M. Khurram Afzal MD on Twitter: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / Twitter M. Khurram Afzal MD on Twitter: "Learn how to calculate the CHADS-VASc and HASBLED score on https://t.co/j6pZUy6NRv #AFibTalk18 #AFib #AFIbAwarenessMonth https://t.co/MOHkn5mYVH https://t.co/Td2GTxbkKu https://t.co/qTkFJld1Qb" / Twitter](https://pbs.twimg.com/media/DnYkH6WUYAABUzV.jpg)